Chemoinformaics analysis of 3-Methoxyphenanthrene-1,4-dione
| Molecular Weight | 238.242 | nRot | 1 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 18 |
| Exact Molecular Weight | 238.063 | nRing | 3 |
| Solubility: LogS | -4.779 | nHRing | 0 |
| Solubility: LogP | 2.808 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 11 |
| nHA | 3 | APOL | 34.1239 |
| nHD | 0 | BPOL | 13.5041 |
| QED | 0.767 |
| Synth | 2.147 |
| Natural Product Likeliness | 1.295 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.038 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.646 |
| MDCK | 0.000021 |
| BBB | 0.11 |
| PPB | 0.9844 |
| VDSS | 0.55 |
| FU | 0.013 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.865 |
| CYP2c19-inh | 0.93 |
| CYP2c19-sub | 0.146 |
| CYP2c9-inh | 0.862 |
| CYP2c9-sub | 0.836 |
| CYP2d6-inh | 0.85 |
| CYP2d6-sub | 0.468 |
| CYP3a4-inh | 0.83 |
| CYP3a4-sub | 0.173 |
| CL | 4.664 |
| T12 | 0.117 |
| hERG | 0.032 |
| Ames | 0.935 |
| ROA | 0.813 |
| SkinSen | 0.93 |
| Carcinogencity | 0.931 |
| EI | 0.978 |
| Respiratory | 0.609 |
| NR-Aromatase | 0.611 |
| Antiviral | Yes |
| Prediction | 0.679337 |